Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 57, Issue 22, pp. 5017-5021
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 2, 1997
- Accepted October 2, 1997
- Published first November 1, 1997.
Copyright & Usage
©1997 American Association for Cancer Research.
Author Information
- Debbie J. Marsh2,
- Stina Roth2,
- Kathryn L. Lunetta,
- Akseli Hemminki,
- Patricia L. M. Dahia,
- Pertti Sistonen,
- Zimu Zheng,
- Stacey Caron,
- Nathalie J. van Orsouw,
- Walter F. Bodmer,
- Sally E. Cottrell,
- Malcolm G. Dunlop,
- Diana Eccles,
- Shirley V. Hodgson,
- Heikki Järvinen,
- Ilmo Kellokumpu,
- David Markie,
- Kay Neale,
- Robin Phillips,
- Paul Rozen,
- Sapna Syngal,
- Jan Vijg,
- Ian P. M. Tomlinson3,
- Lauri A. Aaltonen3, and
- Charis Eng3
- Department of Adult Oncology and Human Cancer Genetics Unit [D. J. M., P. L. M. D., Z. Z., S. C., C. E.], Program in Population Sciences [D. J. M., P. L. M. D., Z. Z., S. C., S. S., C. E.], and Department of Biostatistical Science [K. L. L.], Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115 [D. J. M., P. L. M. D., Z. Z., S. C., N. J. v. O., S. S., J. V., C. E.]; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115 [K. L. L.]; Haartman Institute, Department of Medical Genetics, FIN-00014, University of Helsinki, Helsinki, Finland [S. R., A. H., L. A. A.]; Finnish Red Cross Transfusion Service, FIN-00014 Helsinki, Finland [P. S.]; Second Department of Surgery, Helsinki University Central Hospital, FIN-00014 Helsinki, Finland [H. J., I. K.]; Institute of Molecular Medicine, John Radcliffe Hospital, ICRF Cancer and Immunogenetics Laboratory, Oxford OX3 9DU, United Kingdom [W. F. B.]; ICRF Cancer Genetics Laboratory, London WC2A 3PX, United Kingdom [W. F. B., S. E. C., D. M., I. P. M. T.]; Department of Surgery, University of Edinburgh Royal Infirmary, Midlothian, Scotland [M. G. D.]; Wessex Regional Genetics Service, Princess Anne Hospital, Southampton SO16 5YA, United Kingdom [D. E.]; Department of Medical Genetics, United Medical and Dental School of Guy's and St. Thomas' Hospitals, London SE1 9RT, United Kingdom [S. V. H., D. M.]; Polyposis Registry, St Mark's Hospital, Harrow, Middlesex HA1 3UJ, United Kingdom [K. N., R. P.]; Division of Gastroenterology, Brigham and Women's Hospital, Boston Massachusetts 02115 [S. S.]; Molecular Genetics Section, Gerontology Division, Department of Medicine, Beth Israel Deaconess Medical Centre, Boston, Massachusetts 02115 [N. J. v. O., J. V.]; Department of Gastroenterology, Tel Aviv Medical Center and School of Medicine, IL-64239 Tel Aviv, Israel [P. R.]; Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, United Kingdom [I. P. M. T.]; and Cancer Research Campaign Human Cancer Genetics Research Group, University of Cambridge, Cambridge CB2 2QQ, United Kingdom [C. E.]
November 1997
Volume 57, Issue 22
Volume 57, Issue 22
Exclusion of PTEN and 10q22–24 As the Susceptibility Locus for Juvenile Polyposis Syndrome
Jump to section
Advertisement